Interacting Drugs |
Bezafibrate vs CycloSPORINE (Systemic) |
Security Level |
|
Mechanism |
CycloSPORINE (Systemic): May enhance the nephrotoxic effect of Fibric Acid Derivatives. Fibric Acid Derivatives may decrease the serum concentration of CycloSPORINE (Systemic). |
Management |
Careful consideration of the risks and benefits should be undertaken prior to use of this combination; extra monitoring of renal function and cyclosporine concentrations will likely be required. Adjustment of cyclosporine dose may be necessary. |
Bezafibrate vs CycloSPORINE (Systemic)
Post Review about Bezafibrate vs CycloSPORINE (Systemic) Click here to cancel reply.
Other Interactions of Bezafibrate
Other Interactions of CycloSPORINE (Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.